Posted by Michael Wonder on 24 Aug 2023
CVS Health launches company to produce cheaper ‘biosimilar’ versions of expensive biotech drug
24 August 2023 - CVS Health is launching a new company that will work directly with drug makers to produce and commercialize “biosimilar” drugs, the less expensive versions of expensive brand prescriptions derived from biotechnology.
The name of the new company, Cordavis, will operate as “a wholly owned subsidiary that will work directly with manufacturers to commercialise and/or co-produce biosimilar products,” CVS said in an announcement Wednesday afternoon.
